24.10.2013
- Small But Mighty - Highly potent active ingredients (HPAPIs) are remarkably effective at small doses. Therapies including oncology, hormones, narcotics, musculoskeletal treatments...
11.09.2013
- Familiar Face - Michel Spagnol is no stranger to the chemical industry; Novasep's brand-new CEO has held senior-level positions in companies such as Rhodia and Shasun. He brings...
11.09.2013
- Quality First - As the trend of specialized medicine continues to grow, so does the development of highly potent active pharmaceutical ingredients, better known as HPAPIs. Handling...
09.09.2013
- New Focus - The importance of Indian companies in the global pharmaceutical supply chain is well known and well documented. Large quantities of base chemicals, intermediates...
18.10.2012
- Saltigo, the custom manufacturing business of Lanxess' Advanced Intermediates segment, which achieved total sales of €1.5 billion in 2011, has realigned its strategy. The company...
25.09.2012
- A Spoonful of Safety - Demand in the pharmaceutical industry has sharply increased for the manufacture of targeted and potent drugs that improve efficacy and reduce side effects...
31.08.2012
- Cerbios-Pharma and Xspray Microparticles have signed a letter of intent to develop a long term, mutually beneficial collaboration whereby Xspray will be the preferred technology...
10.08.2012
- Novasep, a supplier of manufacturing solutions to the life sciences industries, announces today a €3 million investment to expand its Highly Potent API (HPAPI) manufacturing...
